Goldman Sachs Group Inc Catalent, Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 764,082 shares of CTLT stock, worth $45.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
764,082
Previous 1,354,441
43.59%
Holding current value
$45.1 Million
Previous $76.2 Million
39.23%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding CTLT
# of Institutions
513Shares Held
149MCall Options Held
575KPut Options Held
2.03M-
Vanguard Group Inc Valley Forge, PA20.2MShares$1.19 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$906 Million0.02% of portfolio
-
State Street Corp Boston, MA7.45MShares$440 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$378 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$267 Million0.14% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.6B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...